In cancer patients, visual identification of sentinel lymph nodes (LNs) is achieved by the injection of dyes that bind avidly to endogenous albumin, targeting these compounds to LNs, where they are efficiently filtered by resident phagocytes 1, 2 . Here we translate this 'albumin hitchhiking' approach to molecular vaccines, through the synthesis of amphiphiles (amph-vaccines) comprising an antigen or adjuvant cargo linked to a lipophilic albumin-binding tail by a solubility-promoting polar polymer chain. Administration of structurally optimized CpG-DNA/peptide amph-vaccines in mice resulted in marked increases in LN accumulation and decreased systemic dissemination relative to their parent compounds, leading to 30-fold increases in T-cell priming and enhanced anti-tumour efficacy while greatly reducing systemic toxicity. Amph-vaccines provide a simple, broadly applicable strategy to simultaneously increase the potency and safety of subunit vaccines.
A major challenge in the development of subunit vaccines is the efficient delivery of antigen/adjuvant to secondary lymphoid organs, where immune responses are orchestrated 3, 4 . Attempts to enhance vaccine delivery have included the use of depot-forming adjuvants 5 or nanoparticulate carriers that are preferentially internalized by antigen presenting cells (APCs) 4, [6] [7] [8] [9] [10] [11] [12] , but approaches that could use well-defined molecular conjugates would be attractive. Antigens conjugated to antibodies targeting dendritic cells reach these cells in the draining LNs but also drain into the systemic circulation and access APCs in distal tissues 13, 14 , which might promote tolerance unless inflammatory adjuvants are systemically co-administered. LN targeting is also required for cancer staging in sentinel LN mapping procedures, in which radioactive or coloured dyes are injected at tumour resection sites 1 . Compounds that bind avidly to serum albumin are particularly effective LN tracers 2 ; albumin binding targets these molecules to lymphatics and draining LNs, where they accumulate in APCs 15, 16 . Inspired by this strategy, we set out to create LN-targeting molecular vaccines designed to similarly 'hitchhike' on albumin to LNs. Exploiting albumin's role as a fatty acid transporter, we proposed that antigens/adjuvants modified with a lipophilic albumin-binding domain would accumulate in lymphoid organs after injection, through in situ complexation and transport with endogenous albumin. To develop this strategy, we studied model vaccines composed of peptide antigens and CpG DNAs, single-stranded oligonucleotides containing unmethylated cytosine-guanine motifs that bind Toll-like receptor 9 (TLR9) and serve as potent molecular adjuvants 17, 18 . To identify an optimal albumin-binding domain that could be appended to either CpG or peptide antigens, we constructed a series of amphiphilic 20-base phosphorothioate (PS)-stabilized CpG oligonucleotides 59-linked to lipophilic tails (amph-CpGs; Fig. 1a ; for synthesis details see Supplementary Information). We first evaluated the interaction of fluorescein amidite (FAM)-labelled conjugates with serum proteins by size-exclusion chromatography (SEC; Fig. 1b) . Fetal bovine serum (FBS) exhibited a major protein fraction eluting at 5.3 min in SEC that coincided with albumin (Extended Data Fig. 1a) . The vast majority of mono-acyl-conjugated (C18-CpG) or cholesterol-conjugated (Cho-CpG) oligonucleotides eluted as monomers at 5.8 min in the presence or absence of serum, indicating a lack of interaction with albumin ( Fig. 1b and Extended Data Fig. 1a) . By contrast, diacyl lipid-conjugated CpGs (lipo-CpGs) in aqueous solution eluted as micelles (3.7 min), but, after incubation with serum, nearly 50% of the lipo-CpGs co-migrated with albumin (Fig. 1b) . Biotinylated lipo-CpG (but not CpG) incubated with FBS and then captured with magnetic beads was found to pull down albumin, and lipo-CpG was efficiently captured by albuminconjugated agarose (Extended Data Fig. 1b, c) . Biolayer interferometry and spectroscopy measurements of fluorescence resonance energy transfer (FRET) between lipo-CpG and purified albumin further confirmed their molecular association in solution (Extended Data Fig. 1d, e) .
We next characterized the in vivo trafficking of CpG conjugates. Amph-CpGs were injected subcutaneously in C57BL/6 mice, and 24 h later, draining LNs were excised intact for in vivo imaging system (IVIS) fluorescence imaging. C18-and Cho-CpG showed marginally increased uptake in LNs relative to unmodified CpG, reaching levels similar to CpG delivered by two prototypical vaccine vehicles known to enhance vaccine accumulation in LNs, incomplete Freund's adjuvant (IFA) or poly(ethylene glycol) (PEG)-coated liposomes 6 (Fig. 1c) . By contrast, lipo-CpG accumulated eightfold more than soluble CpG (Fig. 1c) . Over 7 days after injection, soluble CpG exhibited no LN accumulation above 0.3% of the injected dose at any time, whereas lipo-CpG accumulated for 3 days, giving a 12-fold greater area under the curve (AUC) for total LN exposure to CpG (Fig. 1d) . LN accumulation was not dependent on TLR9-recognized CpG motifs, and was not due to increased nuclease resistance of lipid-modified PSbackbone CpGs (data not shown).
Our in vitro analysis indicated that lipo-CpG molecules equilibrated between micellar and albumin-bound forms in the presence of serum, making it unclear which state was responsible for LN targeting. However, injection of lipo-CpG pre-incubated for 5 h with freshly isolated 90 vol% mouse serum at 37 uC, conditions in which SEC showed the vast majority of the amphiphile co-migrated with albumin, led to essentially identical LN targeting compared with direct lipo-CpG injections (data not shown). To address this question further, we introduced polyguanine repeats between the diacyl lipid and CpG sequence to lock the amphiphiles in the micellar state and block disassembly by albumin. G-quadruplex hydrogen bonding between adjacent oligonucleotide strands in lipo-G n -CpG micelles containing four or more guanine repeats rendered the micelles stable in the presence of serum (Extended Data Fig. 2a-d) . Labelled albumin did not co-migrate with stabilized micelles, as assessed by SEC (Extended Data Fig. 2e) , suggesting that the amphiphiles do not interact with albumin as intact micelles. Despite forming micelles with similar sizes (Extended Data Fig. 2f ), G-quartet-stabilized lipo-G 4 -CpG or lipo-G 6 -CpG micelles exhibited poor LN accumulation after injection compared with albumin-binding lipo-CpG and lipo-G 2 -CpG (Fig. 1d, e) . A possible explanation is that amplification of nonspecific matrix binding by the PS-DNA backbones 19, 20 in the multivalent micellar form irreversibly trapped the stabilized micelles at the injection site. Histological sections of draining LNs showed little detectable CpG or lipo-G 4 -CpG, whereas albumin-binding lipo-CpG and lipo-G 2 -CpG accumulated in the subcapsular sinus and interfollicular areas (Fig. 1f) . LN-accumulating amphiphiles were associated with F4/80 1 macrophages and CD11c 1 dendritic cells, with only a minor contribution from skin-derived CD207 1 dendritic cells ( Fig. 1g and Extended Data Fig. 3 ). If albumin hitchhiking mediates LN targeting, then covalent conjugation of oligonucleotides to albumin should also enhance LN accumulation. We found that injection of CpG conjugated to mouse serum albumin (MSA) led to slightly lower oligonucleotide uptake in LNs than lipo-CpG, but much greater accumulation than soluble CpG (Extended Data Fig. 4) . Altogether, these data suggest that efficient LN delivery of CpG oligonucleotides conjugated to lipophilic tails is enhanced by partitioning of oligonucleotides from micelles into a serum albumin-bound state.
To identify potential differences in the function of CpG versus optimally LN-targeted lipo-G 2 -CpG beyond altered biodistribution, we assessed several aspects of CpG bioactivity in vitro: lipo-G 2 -CpG was internalized by dendritic cells into endolysosomes in a pattern indistinguishable from CpG in confocal microscopy, albeit to twofold higher levels (Extended Data Fig. 5a, b) . Lipo-G 2 -CpG did not activate the lipid-binding receptor TLR2 in reporter cells, but both free CpG and amph-CpG activated RAW macrophages bearing a NF-kB reporter in a CpG sequence-specific manner (Extended Data Fig. 5c, d ). When dendritic cells were activated with CpG or lipo-G 2 -CpG and pulsed with OVA protein to test cross-presentation of antigen to OT-I (OVAspecific) T-cells, dendritic cell activation by soluble or amphiphileCpG led to similar T-cell proliferation (Extended Data Fig. 5e ). Thus, lipid modification of CpG increased uptake in the presence of serum but did not otherwise greatly alter the bioactivity of CpG.
To determine the impact of LN targeting on the immune response, we immunized mice with ovalbumin protein (OVA) mixed with unmodified CpG, Cho-CpG, CpG emulsified in IFA or lipo-G n -CpGs (n 5 0, 2, 4, 6). OVA (which has only 13% sequence identity with albumin) showed minimal association with lipo-CpGs (data not shown) and thus these vaccinations assessed the impact of LN targeting of the adjuvant only, relying on normal lymphatic drainage of the OVA antigen. Lipo-G n -CpG-adjuvanted vaccines primed significantly increased frequencies of antigen-specific, cytokine-producing CD8
1 T cells compared with unmodified CpG, Cho-CpG or CpG in IFA, but the strongest responses (up to 32-fold greater than unmodified CpG) were elicited by lipo-CpG and lipo-G 2 -CpG (Fig. 2a, b and Extended Data Fig. 6a, b) . Notably, the magnitude of the T-cell response was strongly correlated with LN accumulation of CpG (Fig. 2c) . Lipo-CpG also modestly increased antibody responses by approximately threefold and enhanced CD8 Fig. 6g, h ), ruling out a direct adjuvant effect of the diacyl lipid tail. CpG that is not captured in local LNs drains to the systemic circulation, leading to systemic inflammatory toxicities 21 . Despite lymphadenopathy of draining LNs, indicating local activity, repeated injections of lipo-CpGs showed greatly reduced systemic inflammation relative to free CpG (Fig. 2d, e and Extended Data Fig. 7a, b) . Although further work will be needed to determine any potential autoimmune toxicities related to LN targeting of CpG 18 , these results suggest that the LN targeting achieved by amph-CpGs greatly enhances the potency of this molecular adjuvant while simultaneously lowering acute systemic side effects.
Synthesis of lipo-CpG is straightforward owing to the solubility imparted by the long polar oligonucleotide block, but, depending on the amino acid sequence, lipidated polypeptides can be essentially insoluble 22 . 
Lipo-CpG 
1 cells determined by flow cytometry at 24 h. ***P , 0.001, **P , 0.01, *P , 0.05 compared with soluble CpG by one-way analysis of variance (ANOVA) with Bonferroni post-test. Data represent mean 6 standard error of the mean (s.e.m.) of 2-3 independent experiments. NS, not significant.
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To generalize this LN targeting strategy to antigens and other potential vaccine components, we synthesized peptides linked to a diacyl lipid tail via a PEG block chosen to promote conjugate solubility (amph-peptides; Fig. 3a) . Amph-peptides and lipo-PEGs in water form micelles, but these amphiphiles can also insert their diacyl tails into cell membranes. We found that lipo-PEG amphiphiles with short PEG blocks exhibited preferential plasma membrane insertion when incubated with cells in the presence of albumin in vitro (Fig. 3b and Extended Data Fig. 8a, b) , which might limit transit to LNs on albumin in vivo. However, increasing the polar block to 48 ethylene glycol units yielded amphiphiles that partitioned preferentially into solution while retaining albumin binding ( Fig. 3b and Extended Data Fig. 8c) , consistent with previous studies 23 . This in vitro partitioning directly predicted in vivo draining patterns, as lipo-PEG-FAM amphiphiles injected subcutaneously showed increasing LN accumulation with increasing PEG block length (Fig. 3c) . Although optimal immunostimulatory CpGs are ,20 bases, an analogous trend was observed for DNA amphiphiles as a function of oligonucleotide length (Extended Data Fig. 8d, e) . Like amph-CpGs, the structure of the hydrophobic block was also important; whereas lipo-PEG amphiphiles with long diacyl tails ($16 carbons, which exhibit a high affinity for albumin 24 ) showed intense LN accumulation, shorter lipid tails with low affinity for albumin showed low LN accumulation (Fig. 3d) . On the basis of these findings establishing design rules for efficient targeting of lipo-PEG amphiphiles to LNs, we conjugated peptide antigens to 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-PEG (DSPE-PEG 2 kDa) to generate amph-peptides for vaccination studies (Extended Data Fig. 9a) .
To test the potency of combined antigen and adjuvant targeting to LNs, we prepared amph-peptide (DSPE-PEG-peptide) conjugates of a model HIV antigen (AL11 epitope from SIV Gag) 25 , the tumour-associated self-antigen Trp2 from melanoma 26 , and a peptide derived from the human papillomavirus (HPV)-derived cervical cancer antigen E7 (ref. 27 ). Amph-peptides accumulated efficiently in LNs (Extended Data Fig. 9b, c) . C57BL/6 mice immunized with amph-peptides and amph-CpG (lipo-G 2 -CpG) showed markedly increased expansion of antigen-specific, cytokine-producing CD8
1 T-cells and enhanced cytolytic activity relative to unmodified peptide/CpG immunizations (Fig. 4a-c) . To test whether amph-vaccine delivery enhances the protective efficacy of peptide vaccines, animals bearing established TC-1 tumours (expressing the E7 oncoprotein from HPV) or B16F10 melanomas were vaccinated. Amphvaccines triggered sustained regression of large TC-1 tumours that were only modestly affected by soluble vaccines (Fig. 4d) and slowed the growth of melanoma tumours, in which a traditional soluble vaccine had no effect (Fig. 4e) . In addition to enhancing the effectiveness of optimal T-cell epitopes, synthetic 'long peptide' antigens 28 also exhibited enhanced immunogenicity when delivered as amph-peptides (Extended Data Fig. 10a-e) . This result is of particular interest because a finite pool of long sequences permits peptide vaccines to provide effective coverage of epitopes across the diverse haplotypes of a given target patient population. Amphiphile-long peptides were also approximately tenfold more potent than soluble peptides when combined with non-CpG, non-LNtargeted alternative TLR adjuvants (Extended Data Fig. 10f) , showing that CpG is not required for an enhanced response to LN-targeted peptides.
Altogether, the results presented here define design rules for amphiphile conjugates as a general strategy to enhance the potency and safety 
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of LN-active compounds, an approach that may be applicable to a broad range of immunomodulatory therapeutics and imaging agents. These findings also have implications for how the immune system may survey lipophilic antigens. Further work will be needed to determine whether albumin binding is functionally critical, or alternatively whether other rare serum components may have a role in the observed LN targeting.
METHODS SUMMARY
Synthesis of vaccine amphiphiles. Oligonucleotide amphiphiles were synthesized using an ABI 394 synthesizer on a 1.0 mmol scale. All lipophilic phosphoramidites were conjugated as a final 'base' on the 59 end of oligonucleotides 19 . Antigen amphiphiles were synthesized by reacting N-terminal cysteine-modified peptides with maleimide-PEG 2000 -DSPE in dimethyl formamide. Immunizations. Six-to-eight week old C57BL/6 mice (female, Jackson Laboratory) were immunized with 10 mg of antigen mixed with 1.24 nmol CpG adjuvant in 100 ml of PBS subcutaneously at the base of the tail. All procedures were performed under an IUCAC-approved animal protocol in accordance with the guidelines for animal care in a Massachusetts Institute of Technology animal facility inspected by the US Department of Agriculture.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. a, SEC of FBS, albumin and fluorescein-labelled amph-CpGs. FBS and bovine serum albumin (BSA) were monitored using absorptions at 280 nm, whereas CpG oligonucleotides were monitored at 480 nm (fluorescein peak). b, Lipo-CpG, but not CpG, interacts with serum albumin as shown by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) after protein pull-down assays: FBS was incubated with 39-biotin-labelled CpG (CpG-biotin), lipo-CpG (lipo-CpG-biotin) or PBS for 1 h at 37 uC. Streptavidin-conjugated magnetic beads were added to capture biotinylated CpGs and any associated proteins, separated by a magnet, boiled to release bound CpG/proteins, and subjected to SDS-PAGE analysis. Lane 1: protein MW ladder; lane 2: purified BSA; lane 3: FBS (1003 dilution, 10 ml loading); lane 4: pull-down control, FBS incubated with streptavidin-magnetic beads; lane 5: pull-down with CpGbiotin, FBS was incubated with CpG-biotin and streptavidin magnetic beads; lane 6: pull-down with lipo-CpG-biotin, FBS incubated with lipo-CpG-biotin and streptavidin magnetic beads; lane 7: FBS (1003 dilution, 5 ml loading). c, Fluorescein-labelled CpG or lipo-CpG was incubated with albuminconjugated agarose resin for 1 h at 37 uC, and the resin was separated by filtration. The filtrate and recovered agarose were visualized by a gel imager and quantified by fluorescence measurements. d, Bio-layer interferometry measurements of lipo-CpG and CpG binding to immobilized BSA. Albuminconjugated BLI probes were immersed in solutions of lipo-CpG, and wavelength shifts (Dl) of the interferometry pattern association and dissociation curves were followed over time to determine affinity constants of binding at 25 uC. Shown are apparent k on , k off and K D values from fits to the data. e, FRET between FAM-labelled lipo-CpG and rhodamine-conjugated albumin (BSA-Rh) assessed by fluorescence spectroscopy. CpG-F or lipo-CpG-F (1.65 mM) alone or mixed with BSA-Rh (1.5 mM) in PBS were excited at 488 nm and emission was recorded from 500-650 nm.
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Extended Data Figure 2 | Construction and characterization of G-quadruplex-stabilized CpG adjuvants. a, G-quadruplex-stabilized CpG micelles are self-assembled from amphiphiles composed of three distinct segments: an immunostimulatory CpG sequence, a central repeat block containing n 5 1-10 G-quartet-forming guanines followed by (10 2 n) non-interacting thymidines, and a diacyl lipid tail. In aqueous solutions, these amphiphiles self-assembled into three-dimensional spherical micelles with a CpG corona and a lipid core. In the presence of K 1 , neighbouring guanine repeats in the oligonucleotide corona form G-quadruplex structures via Hoogsteen hydrogen bonds and stabilize the micelle structure. The stability of the oligonucleotide micelles in the presence of serum was programmed by altering the length of the guanine repeat. b, Parallel G-quartet formation among DNA strands within the micelles was detected by circular dichroism (CD) spectroscopy, as manifested by the shifting of positive peaks from 278 nm towards 262 nm and troughs at 245 nm as the number of guanines in the structure increased. c, Pyrene excimer fluorescence was used to assay the stabilities of G-quadruplex micelles in the presence of albumin: pyrene dye incorporated in stabilized CpG micelles (n . 2) retained excimer fluorescence in the presence of high concentrations of albumin. By contrast, albumin binds to the lipid moiety of unstabilized micelles (n # 2) and disrupts the micelle structures, leading to loss of excimer fluorescence in an albumin-concentration-dependent manner as the protein disrupts the micelles into albumin-bound unimers. Shown below the schematic is the fraction of amph-CpG remaining in the micellar state as a function of albumin concentration as reported by excimer fluorescence. Arrow indicates the plasma concentration of albumin. d, Stability profiles of G-quadruplex CpG micelles as measured by SEC in the presence of FBS. Fluorescein-labelled CpG micelles were incubated with 20% FBS in PBS in the presence of 10 mM Mg 21 and 20 mM K 1 at 37 uC for 2 h, then analysed by SEC. FBS and BSA were monitored using absorptions at 280 nm, whereas lipo-G n -CpG amphiphiles were monitored at 480 nm (fluorescein peak). Lipo-G n -CpG with n 5 0 or 2 partitioned to co-migrate with albumin, whereas amphiphiles with n . 2 showed increasing fractions of the amphiphiles migrating as intact micelles in the presence of serum with increasing n. e, Fluorescein-labelled lipo-G 6 -CpG (5 mM) and Alexa Fluor 647-labelled BSA (5 mM) were incubated for 2 h at 37 uC in PBS plus 20 mM KCl, and then analysed by SEC. Spectra were monitored at 480 nm (ODN channel, green line, fluorescein) and 640 nm (protein channel, red line, Alexa Fluor 647). The majority of BSA and CpG micellar aggregates eluted separately. f, Size of amph-CpG micelles as determined by dynamic light scattering. All data are mean 6 s.e.m. Statistical analysis was performed by one-way ANOVA with Bonferroni post-tests. RESEARCH LETTER
